Packaging and repackaging: poison prevention packaging, unit dose, repackaging for own use
3 free Uniform MPJE practice questions on this topic, with the answer, a reason for every option and the source. The full bank has 25 questions here.
Which federal agency sets and administers the special packaging standards of the Poison Prevention Packaging Act?
- AThe Food and Drug Administration's drug labeling office
- BThe Consumer Product Safety Commission
- CThe Drug Enforcement Administration
Show answer and sources
Answer: B. The Consumer Product Safety Commission
The Consumer Product Safety Commission administers the Poison Prevention Packaging Act and its standards (16 CFR 1700.2). FDA's role is limited to treating noncompliant packaging as misbranding.
- A. Wrong. FDA treats a PPPA packaging violation as misbranding, but CPSC sets the packaging standards.
- B. Correct. PPPA authority is vested in the Consumer Product Safety Commission (16 CFR 1700.2).
- C. Wrong. DEA regulates controlled substances and has no role in setting PPPA standards.
- [1] 16 CFR Part 1700 — Poison prevention packaging . § 1700.2
A 78-year-old patient with severe arthritis picks up a new lisinopril prescription and asks the pharmacist for an easy-open cap. The prescription says nothing about packaging. Under federal law, the pharmacist:
- Amust first obtain a written order from the prescriber for a non-child-resistant container
- Bmay dispense the lisinopril in a non-child-resistant container at the patient's request
- Cmust refuse, because only the prescriber may waive child-resistant packaging
Show answer and sources
Answer: B. may dispense the lisinopril in a non-child-resistant container at the patient's request
A PPPA-covered prescription drug may be dispensed in noncomplying packaging when the prescriber directs it or when the purchaser requests it (15 U.S.C. 1473(b)).
- A. Wrong. A prescriber order is one route, but a request from the purchaser is also sufficient.
- B. Correct. The purchaser may request noncomplying packaging for a prescription drug.
- C. Wrong. 15 U.S.C. 1473(b) lets the purchaser request noncomplying packaging.
- [1] 15 U.S.C. §1473 — PPPA conventional packages . 15 U.S.C. 1473(b)
A patient returns for a refill of atorvastatin and hands the technician the old plastic prescription vial, asking that it be refilled to reduce waste. The plastic vial and its cap look clean and undamaged. The pharmacy should:
- Adispense the refill in a new child-resistant container
- Brefill the old vial after cleaning it, since it is in good condition
- Crefill the old vial but fit it with a new cap
Show answer and sources
Answer: A. dispense the refill in a new child-resistant container
Special packaging for substances that must be in special packaging shall not be reused (16 CFR 1700.15(c)). A refill goes into new child-resistant packaging.
- A. Correct. Special packaging for substances that require it may not be reused.
- B. Wrong. 16 CFR 1700.15(c) bars reuse of special packaging regardless of its condition.
- C. Wrong. The plastic vial is part of the special packaging, and 16 CFR 1700.15(c) bars its reuse even with a new cap.
- [1] 16 CFR Part 1700 — Poison prevention packaging . § 1700.15(c)
Practise all 25 questions on this topic
Tutor mode, timed blocks and progress tracking.